Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
1-15 of 474
CAR T-Cell Therapy in R/R LBCL: Overcoming Barriers to Referral and Completion
Project Oncology®CAR T-Cell Therapy in R/R LBCL: Overcoming Barriers to Referral and Completion
Alexandria May, PharmD, BCPS
Tara Graff, DO, MS
Making the Most of Biomarker Testing in NSCLC
On the Frontlines of Non-Small Cell Lung CancerMaking the Most of Biomarker Testing in NSCLC
Steve Jackson, PharmD
Angel Qin, MD
Biomarker Testing After Progression in HR+/HER2- mBC
On the Frontlines of Metastatic Breast CancerBiomarker Testing After Progression in HR+/HER2- mBC
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Neoadjuvant and Adjuvant Therapy in Early-Stage NSCLC
On the Frontlines of Non-Small Cell Lung CancerNeoadjuvant and Adjuvant Therapy in Early-Stage NSCLC
Steve Jackson, PharmD
David Carbone, MD, PhD
Emactuzumab in TGCT: Primary Results From the Phase 3 TANGENT Trial
Global Oncology AcademyEmactuzumab in TGCT: Primary Results From the Phase 3 TANGENT Trial
A.J. Gelderblom, MD, PhD
Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Project Oncology®Interpreting Oral SERD Trial Data to Guide Metastatic Breast Cancer Care
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
- advertisement
First-Line ADCs in Metastatic Triple-Negative Breast Cancer
On the Frontlines of Metastatic Breast CancerFirst-Line ADCs in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Heather McArthur, MD, MPH, FASCO
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerZidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley
Alexander Drilon, MD
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Clinician's RoundtableFrom Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD
Paolo F. Caimi, MD
Narendranath Epperla, MD, MS
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP
David A. Johnson, MD, FACG, FACP
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerMolecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS
Timothy F. Burns, MD, PhD
- advertisement
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD